IQV
IQVIA Holdings Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$266.63
−1.84%Forward multiples
Based on analyst estimates
- P/E forward
- 19.59x
- P/E 2026E
- 20.67x
- P/E 2027E
- 18.58x
- P/E 2028E
- 16.60x
- P/S forward
- 2.45x
Trailing multiples
Trailing twelve months
- P/E TTM
- 32.80x
- PEG TTM
- 0.49x
- Price / book
- 7.11x
- Price / sales
- 2.58x
- Price / cash flow
- 15.57x
Enterprise value
- Enterprise value
- $58.2B
- EV / sales
- 3.43x
- EV / EBITDA
- 16.49x
- EV / EBIT
- 25.24x
- Market cap
- $43.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026